AUG 11, 2020 9:00 AM PDT

The Role of Interferon Gamma Release Assay (IGRA) Testing in the TB Testing Program

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

DATE:  August 11, 2020

TIME:   9:00am PDT

 

The goal of TB elimination, less than 1 case per million people per year, can only be achieved through a concerted effort to detect and treat persons infected with TB, which includes those persons with latent TB infection (LTBI). Persons with LTBI have been exposed to TB and although they are not infectious, they are at risk of progressing to active TB disease. Therefore, laboratory tests that can detect persons with LTBI play an essential role. A common way to test for exposure to TB is with a TB skin test (TST). Alternatively, there are blood tests, Interferon Gamma Release Assays (IGRAs). Both methods rely on detecting a person’s immune response if they have been exposed to TB. However, there are some advantages to IGRA testing, particularly since this testing is performed in a controlled laboratory environment and elicits a more specific immune response. This presentation will discuss the pros and cons of performing IGRA testing as part of the TB testing program and the impact of recent changes in IGRA testing methodology.

 

Learning Objectives:

  • Review the role of IGRAs in the diagnosis of TB infection
  • Summarize recent changes in IGRA testing including guidelines associated with testing certain populations
  • Discuss the implementation of IGRA testing in a public health testing program

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
Loading Comments...
Show Resources